The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104088654 10408865 4 F 20120731 20160607 20140826 20160630 PER US-JNJFOC-20140821880 JANSSEN 70.67 YR E F Y 0.00000 20160630 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104088654 10408865 1 SS XARELTO RIVAROXABAN 1 Oral N UNKNOWN 0 20 MG TABLET QD
104088654 10408865 2 SS XARELTO RIVAROXABAN 1 Oral N UNKNOWN 0 20 MG TABLET QD
104088654 10408865 3 PS XARELTO RIVAROXABAN 1 Oral N UNKNOWN 202439 20 MG TABLET QD
104088654 10408865 4 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 0 UNSPECIFIED
104088654 10408865 5 C LIPITOR ATORVASTATIN CALCIUM 1 Unknown 0 UNSPECIFIED
104088654 10408865 6 C COLACE DOCUSATE SODIUM 1 Unknown 0 UNSPECIFIED
104088654 10408865 7 C IRON IRON 1 Unknown 0 UNSPECIFIED
104088654 10408865 8 C LEXAPRO ESCITALOPRAM OXALATE 1 Unknown 0 UNSPECIFIED
104088654 10408865 9 C LISINOPRIL. LISINOPRIL 1 Unknown 0 UNSPECIFIED
104088654 10408865 10 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 0 UNSPECIFIED
104088654 10408865 11 C TRAMADOL. TRAMADOL 1 Unknown 0 UNSPECIFIED
104088654 10408865 12 C VITAMIN E .ALPHA.-TOCOPHEROL 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104088654 10408865 1 Atrial fibrillation
104088654 10408865 2 Thrombosis prophylaxis
104088654 10408865 3 Cerebrovascular accident prophylaxis
104088654 10408865 4 Product used for unknown indication
104088654 10408865 5 Product used for unknown indication
104088654 10408865 6 Product used for unknown indication
104088654 10408865 7 Product used for unknown indication
104088654 10408865 8 Product used for unknown indication
104088654 10408865 9 Product used for unknown indication
104088654 10408865 10 Product used for unknown indication
104088654 10408865 11 Product used for unknown indication
104088654 10408865 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
104088654 10408865 HO
104088654 10408865 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
104088654 10408865 Anaemia
104088654 10408865 Gastrointestinal haemorrhage
104088654 10408865 Thrombosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104088654 10408865 1 20120330 20120731 0
104088654 10408865 2 20120330 20120731 0
104088654 10408865 3 20120330 20120731 0